A detailed history of Equitable Trust CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Equitable Trust CO holds 55,595 shares of MRK stock, worth $6.55 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
55,595
Previous 54,305 2.38%
Holding current value
$6.55 Million
Previous $7.17 Million 3.95%
% of portfolio
0.5%
Previous 0.52%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$123.8 - $132.96 $159,702 - $171,518
1,290 Added 2.38%
55,595 $6.88 Million
Q1 2024

Apr 25, 2024

SELL
$113.24 - $131.95 $281,174 - $327,631
-2,483 Reduced 4.37%
54,305 $7.17 Million
Q3 2023

Nov 07, 2023

BUY
$102.95 - $114.33 $12,148 - $13,490
118 Added 0.21%
56,788 $5.85 Million
Q1 2023

May 08, 2023

SELL
$102.94 - $114.86 $192,394 - $214,673
-1,869 Reduced 3.19%
56,670 $6.03 Million
Q4 2022

Feb 21, 2023

SELL
$87.44 - $112.11 $68,290 - $87,557
-781 Reduced 1.32%
58,539 $6.49 Million
Q3 2022

Nov 03, 2022

BUY
$84.53 - $94.96 $59,593 - $66,946
705 Added 1.2%
59,320 $5.11 Million
Q2 2022

Jul 15, 2022

BUY
$83.49 - $94.64 $225,756 - $255,906
2,704 Added 4.84%
58,615 $5.34 Million
Q1 2022

May 06, 2022

BUY
$73.51 - $82.4 $342,189 - $383,572
4,655 Added 9.08%
55,911 $4.59 Million
Q4 2021

Jan 31, 2022

SELL
$72.28 - $90.54 $1.95 Million - $2.44 Million
-26,983 Reduced 34.49%
51,256 $3.93 Million
Q3 2021

Oct 26, 2021

SELL
$71.68 - $78.83 $34,119 - $37,523
-476 Reduced 0.6%
78,239 $5.88 Million
Q2 2021

Aug 03, 2021

SELL
$70.31 - $77.77 $296,075 - $327,489
-4,211 Reduced 5.08%
78,715 $6.12 Million
Q1 2021

May 14, 2021

SELL
$68.86 - $81.11 $267,589 - $315,193
-3,886 Reduced 4.48%
82,926 $6.39 Million
Q4 2020

Feb 12, 2021

BUY
$71.77 - $79.65 $48,157 - $53,445
671 Added 0.78%
86,812 $7.1 Million
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $8,488 - $9,622
116 Added 0.13%
86,141 $7.15 Million
Q2 2020

Aug 18, 2020

SELL
$70.42 - $80.13 $13,027 - $14,824
-185 Reduced 0.21%
86,025 $6.65 Million
Q1 2020

May 21, 2020

SELL
$63.36 - $87.82 $53,665 - $74,383
-847 Reduced 0.97%
86,210 $6.63 Million
Q4 2019

Feb 18, 2020

SELL
$77.58 - $87.54 $38,712 - $43,682
-499 Reduced 0.57%
87,057 $7.92 Million
Q3 2019

Nov 19, 2019

BUY
$76.08 - $82.93 $169,734 - $185,016
2,231 Added 2.61%
87,556 $7.37 Million
Q2 2019

Aug 16, 2019

BUY
$69.84 - $81.59 $102,315 - $119,529
1,465 Added 1.75%
85,325 $7.16 Million
Q1 2019

May 15, 2019

SELL
$69.58 - $79.36 $222,516 - $253,793
-3,198 Reduced 3.67%
83,860 $6.98 Million
Q4 2018

Feb 22, 2019

BUY
$65.24 - $75.71 $11,873 - $13,779
182 Added 0.21%
87,058 $6.65 Million
Q3 2018

Nov 15, 2018

SELL
$57.69 - $67.84 $271,835 - $319,662
-4,712 Reduced 5.14%
86,876 $6.16 Million
Q2 2018

Aug 14, 2018

BUY
$50.83 - $59.72 $4.66 Million - $5.47 Million
91,588 New
91,588 $5.56 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $299B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Equitable Trust CO Portfolio

Follow Equitable Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitable Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Equitable Trust CO with notifications on news.